FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Promethazine Suppository
Status: Discontinuation
»Therapeutic Categories: Anesthesia; Pulmonary/Allergy

Expand all

Teva Pharmaceuticals (New 04/28/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
25 mg/1 unit, (NDC 0591-2992-39 ) 04/28/2020 Teva evaluated the market and decided to discontinue the product. For Promethazine Hydrochloride 25 mg/1 unit, NDC 0591-2992-39, allocations are being made based on customer Rx trends. Product availability is anticipated until May, 2020
12.5 mg/1 unit, (NDC 0591-2985-39) 04/28/2020 Teva evaluated the market and decided to discontinue the product. For Promethazine Hydrochloride 25 mg/1 unit, NDC 0591-2992-39, allocations are being made based on customer Rx trends. Product availability is anticipated until May, 2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English